Literature DB >> 2984231

The immune response to poliovirus-specific synthetic peptides: effects of adjuvants and test animal species.

E A Emini, W A Schleif, B A Jameson, E Wimmer.   

Abstract

Carrier protein conjugates of five synthetic peptides containing amino acid sequences specific to capsid proteins VP1 and VP2 of poliovirus type 1 were tested for their abilities to elicit an immune response in the presence of either of two adjuvants and in several animal species. Freund's adjuvant induced significantly higher level anti-peptide antibody titers than A1(OH)3. However, no difference was noted between the two adjuvants in their abilities to aid in the induction of cross-reactive virus neutralizing antibody. The latter antibody was more readily produced by rabbits than by guinea pigs in spite of equivalent anti-peptide titers. Rats failed to produce neutralizing antibodies and their anti-peptide antibody levels were generally lower. The significance of these results for studies involving the development of synthetic peptide immunogens is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984231     DOI: 10.1016/0166-0934(85)90102-8

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  1 in total

Review 1.  Adjuvants and inactivated polio vaccine: a systematic review.

Authors:  Jennifer Hawken; Stephanie B Troy
Journal:  Vaccine       Date:  2012-10-03       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.